About

Martin Junginger is the Global Category Manager for Pharma & Bioscience at GELITA. He joined the company in 2017 and has extensive experience in the field of medical devices. He is the expert responsible for the strategic management and development of the pharmaceutical-grade gelatine portfolio. His particular focus is on soft capsule applications and advanced excipient solutions. He is the driving force behind the Endotoxin Controlled Excipient portfolio, which supports emerging bioscience applications, such as regenerative medicine, vaccine stabilisation and tissue engineering. He also oversees GELITA’s global innovation process and plays a key role in GELITA’s Pharma Institute.

Mr Junginger has more than 20 years of experience in the medical device field. He has a strong background in regulated product and process development. This enables him to translate complex technical and regulatory requirements into market-ready pharmaceutical and bioscience solutions.